Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome.

Altermanini, Mohammad; Habib, Mhd Baraa; Alkhiyami, Dania; Ali, Khaled; Abdelghani, Mohamed Salah; Hamamyh, Tahseen; Elyas, Ahmad; Elhassan, Mawahib

Altermanini, Mohammad; Habib, Mhd Baraa; Alkhiyami, Dania; Ali, Khaled; Abdelghani, Mohamed Salah; Hamamyh, Tahseen; Elyas, Ahmad; Elhassan, Mawahib.

Afiliación

Altermanini M; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Habib MB; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Alkhiyami D; Hamad Medical Corporation, Doha, Qatar.
Ali K; Community Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Abdelghani MS; Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Hamamyh T; Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Elyas A; Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Elhassan M; Department of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Heliyon ; 9(8): e18716, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37576199

Palabras clave

BNT162b2; Brugada; COVID-19; Coronavirus; Syncope; Vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article País de afiliación: Qatar